EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Comprehensive Review of Small-Molecule Inhibitors Targeting Bruton Tyrosine Kinase: Synthetic Approaches and Clinical Applications

Qi Zhang, Changming Wen, Lijie Zhao, Yatao Wang

Molecules · 11.12.2023 · 28 (24) · 8037

DOI: 10.3390/molecules28248037 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 11.12.2023. Verfasst von Qi Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nanyang Central Hospital, Nanyang 473000, China. Hauptthemen laut MEDLINE: Protein-Tyrosine Kinases, Leukemia, Lymphocytic, Chronic, B-Cell. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bruton tyrosine kinase (BTK) is an essential enzyme in the signaling pathway of the B-cell receptor (BCR) and is vital for the growth and activation of B-cells. Dysfunction of BTK has been linked to different types of B-cell cancers, autoimmune conditions, and inflammatory ailments. Therefore, focusing on BTK has become a hopeful approach in the field of therapeutics. Small-molecule inhibitors of BTK have been developed to selectively inhibit its activity and disrupt B-cell signaling pathways. These inhibitors bind to the active site of BTK and prevent its phosphorylation, leading to the inhibition of downstream signaling cascades. Regulatory authorities have granted approval to treat B-cell malignancies, such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), with multiple small-molecule BTK inhibitors. This review offers a comprehensive analysis of the synthesis and clinical application of conventional small-molecule BTK inhibitors at various clinical stages, as well as presents promising prospects for the advancement of new small-molecule BTK inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein-Tyrosine KinasesLeukemia, Lymphocytic, Chronic, B-CellHumansAdultAgammaglobulinaemia Tyrosine KinaseB-LymphocytesSignal Transduction

Stichwörter der Autor:innen

BTKapplicationdrugssmall-moleculesynthesis

Substanzen

Agammaglobulinaemia Tyrosine KinaseProtein-Tyrosine Kinases

Autor:innen und Institutionen

  • Nanyang Central Hospital, Nanyang 473000, China.
  • The Rogel Cancer Center, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
  • First People's Hospital of Shangqiu, Shangqiu 476100, China.
  • Department of Orthopedics, China-Japan Union Hospital, Jilin University, Changchun 130033, China.

Zitieren

APA

Zhang, Q., Wen, C., Zhao, L., & Wang, Y. (2023). A Comprehensive Review of Small-Molecule Inhibitors Targeting Bruton Tyrosine Kinase: Synthetic Approaches and Clinical Applications. Molecules, 28(24), 8037. https://doi.org/10.3390/molecules28248037

Vancouver

Zhang Q, Wen C, Zhao L, Wang Y. A Comprehensive Review of Small-Molecule Inhibitors Targeting Bruton Tyrosine Kinase: Synthetic Approaches and Clinical Applications. Molecules. 2023;28(24):8037. doi:10.3390/molecules28248037

BibTeX
@article{Zhang2023,
  author = {Zhang, Qi and Wen, Changming and Zhao, Lijie and Wang, Yatao},
  title = {A Comprehensive Review of Small-Molecule Inhibitors Targeting Bruton Tyrosine Kinase: Synthetic Approaches and Clinical Applications},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {24},
  pages = {8037},
  doi = {10.3390/molecules28248037}
}
Kostenlos starten →